← All stocks

Artiva Biotherapeutics, Inc.

ARTV Net buying
CIK 0001817241 #3037 in the set updated 17 Sep 2026
Bought (12 mo)
$109.12M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$1.94M
$449.39K on a plan · $103.88K straight out of an exercise
Sold at will
$1.39M
9 of 15 sales
Net
+$107.18M
+$107.73M against sales at will

By person

11 insiders · 36 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$92.62M (19)
+$92.62M
17,329,570
$189.17M
+99.3%
GC Corp. entity
10% owner
$16.50M (2)
+$16.50M
5,999,703
$65.49M
+31.4%
Aslan Fred
Chief Executive Officer
$1.38M (6)
−$1.38M
1,604,765
$17.52M
+640.7%
Banerjee Subhashis
Chief Medical Officer
$179.54K (4) scheduled
−$179.54K
170,947
$1.87M
Horan Christopher
Chief Tech Operations Officer
$178.71K (2)
−$178.71K
323,084
$3.53M
+1,192%
Bush Jennifer
COO, CLO, Compliance Officer
$172.78K (2)
−$172.78K
374,529
$4.09M
+414.5%
Raymon Heather
SVP, Research and Development
$27.88K (1)
−$27.88K
148,228
$1.62M
+1,382%
Huston Thad Allen
Chief Financial Officer
220,000
$2.40M
Miralles Gines Diego
President & Head of R&D
122,500
$1.34M
Krishnamohan Neha
Chief Financial Officer
99,356
$1.08M
+98.7%
Graef Thorsten
Chief Medical Officer
80,000
$873.26K
+300.0%

No percentages here. This company's share count has moved by a factor of 2.0 over the window, from 24,289,328 to 48,890,121 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 61
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 2
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 2,534,096
History held since 22 Jul 2024